Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/98224
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Health Technology and Informaticsen_US
dc.creatorZhang, Ren_US
dc.creatorAi, QYHen_US
dc.creatorWong, LMen_US
dc.creatorGreen, Cen_US
dc.creatorQamar, Sen_US
dc.creatorSo, TYen_US
dc.creatorVlantis, ACen_US
dc.creatorKing, ADen_US
dc.date.accessioned2023-04-24T05:50:33Z-
dc.date.available2023-04-24T05:50:33Z-
dc.identifier.urihttp://hdl.handle.net/10397/98224-
dc.language.isoenen_US
dc.publisherMDPI AGen_US
dc.rights© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).en_US
dc.rightsThe following publication Zhang, R., Ai, Q. Y. H., Wong, L. M., Green, C., Qamar, S., So, T. Y., ... & King, A. D. (2022). Radiomics for discriminating benign and malignant salivary gland tumors; which radiomic feature categories and MRI sequences should be used? Cancers, 14(23), 5804 is available at https://doi.org/10.3390/cancers14235804.en_US
dc.subjectRadiomicsen_US
dc.subjectSalivary gland neoplasmsen_US
dc.subjectConventional magnetic resonance imagingen_US
dc.titleRadiomics for discriminating benign and malignant salivary gland tumors; Which radiomic feature categories and MRI sequences should be used?en_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.volume14en_US
dc.identifier.issue23en_US
dc.identifier.doi10.3390/cancers14235804en_US
dcterms.abstractThe lack of a consistent MRI radiomic signature, partly due to the multitude of initial feature analyses, limits the widespread clinical application of radiomics for the discrimination of salivary gland tumors (SGTs). This study aimed to identify the optimal radiomics feature category and MRI sequence for characterizing SGTs, which could serve as a step towards obtaining a consensus on a radiomics signature. Preliminary radiomics models were built to discriminate malignant SGTs (n = 34) from benign SGTs (n = 57) on T1-weighted (T1WI), fat-suppressed (FS)-T2WI and contrast-enhanced (CE)-T1WI images using six feature categories. The discrimination performances of these preliminary models were evaluated using 5-fold-cross-validation with 100 repetitions and the area under the receiver operating characteristic curve (AUC). The differences between models’ performances were identified using one-way ANOVA. Results show that the best feature categories were logarithm for T1WI and CE-T1WI and exponential for FS-T2WI, with AUCs of 0.828, 0.754 and 0.819, respectively. These AUCs were higher than the AUCs obtained using all feature categories combined, which were 0.750, 0.707 and 0.774, respectively (p < 0.001). The highest AUC (0.846) was obtained using a combination of T1WI + logarithm and FS-T2WI + exponential features, which reduced the initial features by 94.0% (from 1015 × 3 to 91 × 2). CE-T1WI did not improve performance. Using one feature category rather than all feature categories combined reduced the number of initial features without compromising radiomic performance.en_US
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationCancers, Dec. 2022, v. 14, no. 23, 5804en_US
dcterms.isPartOfCancersen_US
dcterms.issued2022-12-
dc.identifier.isiWOS:000896206300001-
dc.identifier.pmid36497285-
dc.identifier.eissn2072-6694en_US
dc.identifier.artn5804en_US
dc.description.validate202304 bckwen_US
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_Others-
dc.description.fundingSourceSelf-fundeden_US
dc.description.pubStatusPublisheden_US
dc.description.oaCategoryCCen_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
cancers-14-05804.pdf2.5 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

120
Last Week
0
Last month
Citations as of Nov 9, 2025

Downloads

43
Citations as of Nov 9, 2025

SCOPUSTM   
Citations

17
Citations as of Dec 19, 2025

WEB OF SCIENCETM
Citations

18
Citations as of Dec 18, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.